We observed an increasing trend of the median CD4 + cell count in women without AHD during the 36 months follow-up (p < 0.001), however, this remained constantly below 200 cells/mm3 in women presenting with AHD at first ANC clinic visit. The gene discussed is CD4; the disease is mitochondrial DNA depletion syndrome 4a.